For years, Teva has supported patients living with HIV and we continue to do so by delivering quality, cost-effective treatment options to patients. Let’s look at some facts:
While we’ve made strides in preventing the spread of this potentially fatal virus, we also recognize the need to continue supporting communities and patients in addition to increasing access to treatment – especially during the COVID-19 pandemic, when access to treatment for immunocompromised patients is more important than ever. Consider these facts:
Prevention is the first step for reducing HIV risk. Condom use is the most effective method for preventing STDs and HIV in any sexual encounter. A routine blood test can help monitor HIV status. There are also preventive medications that can be taken daily or after potential exposure.
Treating HIV is part of our broader mission to nurture healthy communities around the world, through our portfolio and beyond.
IQVIA MIDAS MAT (Q3 2018, Q4 2018, Q1 2019, Q2 2019). Global analysis of 32 countries.
World Health Organization. Essential Medicines List 21st Edition. 2019. Available: https://www.who.int/medicines/publications/essentialmedicines/UNEDITED_TRS_2019_EC22_Sept.pdf?ua=1
UNAIDS announces nearly 21 million people living with HIV now on treatment. 2017. Available: https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2017/november/20171121_righttohealth_report
World Health Organization. HIV/AIDS Key Facts. 2019.Available: https://www.who.int/news-room/fact-sheets/detail/hiv-aids
Global HIV & AIDS statistics – 2019 fact sheet. 2019. Available: https://www.unaids.org/en/resources/fact-sheet